ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Weighted Avg Shares
Average number of basic shares outstanding during the period, used to calculate basic EPS.
Weighted Avg Shares history
Shares · from the income statement
No Weighted Avg Shares data reported for this period type.
Weighted Avg Shares vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | 178.01M | +21.7% | +28.8% | |
| LTM Mar 2026 | 153.89M | +26.0% | +15.2% | |
| LTM Mar 2026 | 104.77M | +19.6% | +13.7% | |
| LTM Mar 2026 | 80.99M | +13.7% | +21.2% | |
| LTM Mar 2026 | 59.6M | +5.0% | +15.0% | |
| LTM Mar 2026 | 43.27M | +112.6% | +166.1% | |
| LTM Mar 2026 | 31.49M | — | +63.9% | |
| LTM Mar 2026 | 27.53M | +1.8% | +1.2% | |
| FY2025 | 17.11M | — | — | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — |
| Peer median (excluding ADRX) | 59.6M | +19.6% | +18.2% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.